{
    "organizations": [],
    "uuid": "d4459e2966838c22af22b171116343ca6a5b5589",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-genetic-technologies-enters-into-a/brief-genetic-technologies-enters-into-a-non-binding-terms-sheet-with-omix-ventures-private-idUSFWN1QN0U9",
    "ord_in_thread": 0,
    "title": "BRIEF-Genetic Technologies Enters Into A Non-Binding Terms Sheet With Omix Ventures Private ​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 6 (Reuters) - Genetic Technologies Ltd:\n* ENTERED INTO A NON-BINDING TERMS SHEET WITH OMIX VENTURES PRIVATE ​\n* AGREEMENT WILL ENHANCE CO’S ‍DEVELOPMENT OF PREDICTIVE CANCER TESTS THROUGH ACCESS TO A LARGE POPULATION AND NEW MARKETS​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-06T14:17:00.000+02:00",
    "crawled": "2018-03-07T19:55:18.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "genetic",
        "technology",
        "ltd",
        "entered",
        "term",
        "sheet",
        "omix",
        "venture",
        "private",
        "agreement",
        "enhance",
        "co",
        "predictive",
        "cancer",
        "test",
        "access",
        "large",
        "population",
        "new",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}